Herbas VPB

Print
EN | LT
LT - COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER
EN - COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/395 (2006.01)
C07K 16/30 (2013.01)
A61P 35/00 (2006.01)
A61K 39/39558 (2013.01)
C07K 16/30 (2006.01)
C07K 16/2803 (2013.01)
A61K 31/357 (2006.01)
C07K 16/2887 (2013.01)
A61P 35/02 (2006.01)
C07K 16/3007 (2013.01)
A61K2039/505 (2013.01)
A61P 35/04 (2006.01)
A61P 43/00 (2006.01)
A61K2039/545 (2013.01)
C07K 16/28 (2006.01)
C07K2317/24 (2013.01)
A61K 39/00 (2006.01)
C07K2317/73 (2013.01)
A61K 47/68 (2017.01)
C07K2317/732 (2013.01)
A61K 45/06 (2006.01)
C07K2317/94 (2013.01)
A61K 31/337 (2006.01)
A61K 47/6803 (2017.08)
A61K 31/502 (2006.01)
A61K 47/6849 (2017.08)
A61K 31/519 (2006.01)
A61K 47/6851 (2017.08)
A61K 31/52 (2006.01)
A61K 47/6853 (2017.08)
A61K 45/06 (2013.01)
A61K 31/337 (2013.01)
A61K 31/357 (2013.01)
A61K 31/502 (2013.01)
A61K 31/519 (2013.01)
A61K 31/52 (2013.01)
A61P 35/00 (2018.01)
A61P 35/02 (2018.01)
A61P 35/04 (2018.01)
A61P 43/00 (2018.01)
European patent
(11) Number of the document 3313443
(13) Kind of document T
(96) European patent application number 16815285.8
Date of filing the European patent application 2016-06-23
(97) Date of publication of the European application 2018-05-02
(45) Date of publication and mention of the grant of the patent 2023-06-07
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2016/038986
Date 2016-06-23
PCT application publication
(87) Number WO 2016/210108
Date 2016-12-29
Priority applications
(30) Number Date Country code
201562184331 P 2015-06-25 US
201562201361 P 2015-08-05 US
201562250715 P 2015-11-04 US
201562263134 P 2015-12-04 US
201615069208 2016-03-14 US
Inventors
(72)
GOLDENBERG, David M. , US
CARDILLO, Thomas, M. , US
Grantee
(73) Immunomedics, Inc. , 300 American Road, Morris Plains, NJ 07950, US
Title
(54) COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER
  COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER